Search
for

    Sort by

    Research 30 of 1000+

    1. Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement The Journal of Urology · 2012
    2. QUALITY ASSESSMENT OF HERBAL MEDICINAL PRODUCTS IN BENIGN PROSTATE HYPERTROPHY: CHEMICAL MARKERS AND FINGERPRINT ANALYSIS Bulletin of Pharmaceutical Sciences Assiut · 2023
    3. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    4. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    5. The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them? MAEDICA – a Journal of Clinical Medicine · 2025
    6. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study BJUI · 2015 · 31 citations
    7. 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS The Journal of Urology · 2013
    8. Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia The Journal of Urology · 2010 · 20 citations
    9. PD14-05 ECONOMIC IMPLICATIONS OF UROLOGIST PRESCRIPTION PRACTICES AMONG MEDICARE PART D BENEFICIARIES 2017
    10. Methylated CpG dinucleotides in 5-α reductase 2 gene might explain the finasteride-resistance in BPE patients European urology open science · 2020
    11. Combination of finasteride and tamsulosine in the treatment of male lower urinary tract symptoms: What patients are thinking about? European Urology Supplements · 2018
    12. GYNECOMASTIA AFTER FINASTERIDE THERAPY Southern Medical Journal · 1995 · 3 citations
    13. Finasteride Elsevier eBooks · 2015
    14. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    15. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    16. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement Urology Annals · 2024 · 2 citations
    17. An observational study of the association between androgenetic alopecia and size of the prostate International Journal of Trichology · 2016 · 6 citations
    18. Alopecia androgénica como factor predictor de hiperplasia benigna de próstata Universidad Privada Antenor Orrego · 2018
    19. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    20. 테스토스테론으로 유도된 전립선 비대증에 대한 Sapium rotundifolium Hemsl. 추출물의 효과 KMOU Repository (Korea Maritime and Ocean University) · 2019
    21. Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male Journal of the American Geriatrics Society · 1984 · 23 citations
    22. Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation Annals of Translational Medicine · 2021 · 4 citations
    23. Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis The World Journal of Men's Health · 2019 · 4 citations
    24. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase Scientific Reports · 2016 · 43 citations
    25. Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats Frontiers in Pharmacology · 2025 · 2 citations
    26. Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq Baghdad Science Journal · 2020 · 2 citations
    27. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    28. 40gm 미만의 전립선비대증에서 α-차단제와 Finasteride 병합요법의 유용성 2003
    29. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    30. The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride International Braz J Urol · 2008 · 24 citations